Search
Teva Pharmaceutical Industries Ltd
TEVAAdd to Watchlist
33.210USD
+1.010+3.14%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
38.24BMarket Cap
26.97P/E TTM
More Details of Teva Pharmaceutical Industries Ltd Company
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd Info
Ticker SymbolTEVA
Company nameTeva Pharmaceutical Industries Ltd
IPO dateFeb 06, 2087
CEOFrancis (Richard D)
Number of employees33892
Security typeDepository Receipt
Fiscal year-endFeb 06
Address124 Dvora Hanevi'a St.
CityTEL AVIV-YAFO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryIsrael
Postal code6944020
Phone97239148213
Websitehttps://www.tevapharm.com/
Ticker SymbolTEVA
IPO dateFeb 06, 2087
CEOFrancis (Richard D)
Company Executives of Teva Pharmaceutical Industries Ltd
Name
Name/Position
Position
Shareholding
Change
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Roberto A. Mignone
Mr. Roberto A. Mignone
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
FAQs
Who are the top five shareholders of Teva Pharmaceutical Industries Ltd?
The top five shareholders of Teva Pharmaceutical Industries Ltd are: Prof. Varda Shalev
How many institutions hold shares of Teva Pharmaceutical Industries Ltd (TEVA)?
As of 2026Q1, 1226 institutions hold shares of Teva Pharmaceutical Industries Ltd, with a combined market value of approximately 725.07M, accounting for 62.27% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 9191465.00.
What is the biggest source of revenue for Teva Pharmaceutical Industries Ltd?
In 2026Q1, the Generic products business generated the highest revenue for Teva Pharmaceutical Industries Ltd, amounting to 9.42B and accounting for 54.59% of total revenue.
